They showed that overexpression of MUC1 in over 80% of PDA patients and its aberrant expression increases the levels of NRP-1 and VEGF, which subsequently causes a pro-angiogenic tumor microenvironment. This evidence concerns the gene MUC1 and Patent ductus arteriosus.